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Abstract
Objective To review the role of ultrasound-guided core-
needle biopsy (CNB) in the management of breast lesions.
Methods Review of the most relevant literature on this
topic.
Results This technique shows a high sensitivity value of
about 97.5% and it offers many advantages over other
imaging techniques to guide a biopsy: non-ionising radiation,
low cost, full control of the needle in real time, accessibility in
difficult locations, multidirectional punctures and excellent
comfort for patients and radiologists. All of these advantages
have made this technique the most widespread used to
perform a biopsy for a suspicious breast lesion. The most
important limitation is the failure to perform a biopsy for
lesions that are not seen on ultrasound. An adequate
radiological–pathological correlation is necessary to minimise
the false-negative results.
Conclusion Ultrasound-guided CNB has proven to be a
reliable technique for performing a biopsy for breast lesions
that can be clearly seen on ultrasound.
Keywords Core needle . Biopsy . Ultrasound guided .
Breast
Introduction
Nowadays, percutaneous imaging-guided breast biopsy is a
reliable alternative to surgical biopsy for a histological
diagnosis [1–5]. Percutaneous biopsy is less invasive than
surgery, can be performed quickly, does not deform the
breast, causes minimal scarring, complications (haematoma
and infection) are infrequently found (less than one case in
1,000), fewer surgeries are needed for patients who undergo
percutaneous biopsies and therefore the cost of diagnosis is
lower [1–5].
There are two main objectives of percutaneous biopsy
techniques: first, achieving the maximum degree of
accuracy and second, offering as much information as
possible about the tumour (type, grade, invasion, hormonal
receptors, HER-2 NEU, etc.). To achieve these objectives,
the percutaneous biopsy devices have evolved, from fine-
needle aspiration cytology towards core-needle biopsy
(CNB) and later vacuum-assisted biopsy (VAB) [1].
Nowadays, ultrasound-guided core needle breast biopsy
has become the first choice for performing a percutaneous
biopsy for most lesions seen on ultrasound [1, 6–9].
Virtually any breast lesion that is clearly seen on ultrasound
can be sampled under ultrasound guidance [6]. Many
surgical biopsies that had to be carried out in the past,
because of suspicious radiological findings, are nowadays
unnecessary due to the extensive use of ultrasound NCB. In
addition, surgical specimens removed after a previously
proven malignant result are usually more adequate for the
tumour size. Consequently, the number of surgical proce-
dures has also been reduced for malignant lesions. Thus,
the number of surgical procedures has drastically decreased
both for benign and malignant lesions, thanks to the
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extensive use of ultrasound CNB and the other methods of
percutaneous biopsy.
The technique was first described by Parker and co-
workers in the early 1990s, and nowadays ultrasound CNB
has become the first choice for performing most breast
biopsies [2, 4, 5, 9].
Advantages and limitations of ultrasound NCB
The numerous advantages of ultrasound guidance over
stereotactic and MR guidance have been key in explaining
the widespread use of this technique. Noteworthy among
these advantages are:
& Ultrasound involves non-ionising radiation.
& Full control of the needle position in real time. Neither
stereotactic guidance nor MR guidance offers this
advantage.
& Ultrasound equipment is cheaper and more readily
available than stereotactic or MR units.
& Accessibility of difficult places, such as the axilla or
near the nipple. These are limitations for stereotactic or
MR guidance.
& Multiple lesions (unilateral or bilateral) can be safely
biopsied in one session, usually more quickly than with
other imaging techniques.
& The breast is not compressed.
& Excellent comfort for patients and radiologists, although
stereotactic prone tables are also comfortable for both.
& Local anaesthesia and haematoma do not hide the lesion
(non-calcified masses can be obscured with use of
stereotactic equipment). However, bubbles injected with
the local anaesthesia can obscure the lesion.
& It is a cost-effective technique: Liberman et al. [8]
found that ultrasound CNB yielded a 56% decrease in
the cost of diagnosis. For masses amenable to either
stereotactic or ultrasound guidance, cost savings are
greater if the biopsy is performed under ultrasound
guidance [8]. According to Schueller et al. [10], overall
cost savings for ultrasound CNB over surgical biopsy
were 977 euros [10].
The main disadvantage of ultrasound CNB is the
limitation of performing a biopsy for lesions not seen on
ultrasound. Most clustered microcalcifications, especially if
they are not inside a mass, cannot be identified on
ultrasound. However, high-resolution transducers can dem-
onstrate some clustered microcalcifications even in the
absence of a mass.
Although most ultrasound CNB procedures are easy to
perform, in some special situations (deeply located lesions,
patients with implants, axillary lesions, etc.) a high level of
experience is needed to get reliable results.
Current indications and contraindications
All lesions classified as BI-RADS 4 and 5, clearly visible
on ultrasound, are amenable to ultrasound CNB [6]. This
technique can also be used for some BI-RADS 3 lesions
under certain circumstances: genetic or family risk, medical
or social difficulties for follow-up, pregnancy, extreme
anxiety and others, including the patient’s decision.
Ultrasound CNB can be difficult in patients with severe
psychiatric disorders, which makes them impossible to
collaborate on, and is contraindicated in some cases of severe
blood dyscrasia. However, there are no statistically significant
differences in haematoma formation between patients taking
anticoagulant therapy daily and non-treated patients [11].
Thus, it is not necessary to stop that therapy to perform an
ultrasound CNB. Expert radiologists can perform biopsies of
very deep lesions located close to the pectoral muscle in
large breasts. Obtaining a biopsy in some patients with
silicone implants can be also contraindicated.
Palpable lesions can be safely biopsied under ultrasound
guidance. Although surgeons have been using CNB guided
by palpation for a long time [12], the accuracy is increased
with ultrasound guidance [13].
As well as diagnostic objectives, ultrasound guidance
allows us to perform other interesting therapeutic procedures
such as evacuation of liquid or semi-solid collections and
placement of markers or coils for neoadjuvant chemotherapy.
More recently, ultrasound guidance has been useful for
tumour ablation using radiofrequency, cryoablation, laser
therapy or focused ultrasound [14–16].
Technical procedure
There is a wide spectrum of core-needle devices that can be
used under ultrasound guidance (Fig. 1). The thickness of
Fig. 1 A small sample of the great variety of biopsy devices that can
be used under ultrasound guidance
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the needles can be selected, varying from 18- to 8-gauge;
however, 14-gauge conventional Tru-cut devices have
been the most commonly used [6]. Nowadays there is a
trend towards using 10- to 11-gauge vacuum-assisted
devices.
It is very important to correlate mammography, ultra-
sound and MRI findings, in order to carry out the puncture
using the most suitable method of guidance. Sometimes it is
necessary to perform several biopsies in the same patient
using different techniques of imaging guidance (i.e. micro-
calcifications under stereotactic guidance and a mass, only
visible on ultrasound, under ultrasound guidance). Metallic
markers can be placed superficially on the skin close to the
lesion or inside the lesion to correlate ultrasound and
mammography findings.
The use of high-frequency (10- to 12-MHz) probes,
adjustments in the dynamic range and postprocessing grey
scales, as well as correct focus, are important to improve
the visibility of breast lesions.
The patients should have a complete, thorough level of
information about the technique, indications, contraindica-
tions, complications and alternative possibilities; therefore,
obtaining informed consent is mandatory. Local anaesthesia
must be injected superficially and also as deeply as
necessary, under sterile conditions. This anaesthesia does
not mask the lesion and sometimes can help us to move it to
another, more accessible place, deeper or more superficial.
However, bubbles mixed with the anaesthesia can mask the
lesion; thus, they must be avoided.
After localising the lesion with ultrasound, the procedure is
performed in an outpatient setting, using the free-hand
technique: one hand holds the probe and the other hand holds
the needle (Fig. 2). One of the main advantages of ultrasound-
guided CNB is the full control of the needle position in real
time, allowing for corrections in the needle direction.
As a general rule, the shortest route from the skin to the
lesion should be used. A vertical approach would be the
best, but it is not possible under ultrasound guidance.
However, an oblique approach, as parallel to the chest wall
as possible, should be used (Fig. 3). This is the way to
avoid pneumothorax, the worst complication of this
technique. This approach also enables the best visualisation
of the needle, because even large-gauge needles are difficult
to visualise if a steep angle is used because of less reflective
echoes. However, when the needle is parallel to the probe,
the number of needle-generated reflected echoes that are
perpendicular to the ultrasound beam is maximised, so the
needle can be identified. This horizontal approach can be
used to perform a biopsy for cutaneous lesions (Fig. 4).
Fig. 2 These pictures illustrate
how the ultrasound CNB
procedure is performed. a Local
anaesthesia is injected, b a
small incision is required
and c the biopsy device is
guided by ultrasound
Fig. 3 The approach to the lesion should be as parallel to the chest
wall as possible to avoid pneumothorax. Moreover the transducer
should be orientated parallel to the needle in order to facilitate the
needle visualisation
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It is useful to move the patient to lateral decubitus
positions, especially in the case of deeply located lesions or
peripheral masses. If possible, an approach through fat is
preferable, because the puncture is easier (the fat is soft and
the needle can be easily guided; Fig. 5).
It is important to insert the tip of the needle inside the
mass, because there is a dead space behind the tip. If the tip
is not inserted, then part of the specimen will not belong to
the lesion but to the perilesional tissue, and there is a risk of
lancing the lesion, especially if it is very hard. Necrotic
tissue inside the lesion should not be targeted. Pre-fire and
post-fire images are important to ensure the correct position
of the needle and to rule out the occurrence of complica-
tions (Fig. 6).
In the case of very dense breasts, the punction can be
difficult. There are some tricks that can be used:
& Coaxial technique: once the coaxial needle is inserted in
the lesion, the inner trocar can be removed and replaced
by the biopsy needle [6].
& A 16-gauge needle instead of a 14-gauge one. The
smaller diameter, the lower friction with the surround-
ing tissue. The punction is easier and the strength of the
shot is greater.
& Stronger devices, such as vacuum-assisted devices.
& Devices with diamond-shaped needle tips, because they
transverse the fibrous tissue better than conventional
needles (Fig. 7).
In the case of deeply located lesions there is a need to
use a parallel approach to the chest wall, so that this
structure is not penetrated and pneumothorax is avoided.
Other tricks that can be used include:
Fig. 4 An ultrasound CNB is
performed in this cutaneous
metastasis (arrows). Note the
horizontal approach needed in
this case
Fig. 5 A puncture through a fat lobule is easier than through fibrous
dense tissue
Fig. 6 One of the main advantages of ultrasound CNB is the full
control of the needle direction in real time. Pre-fire and post-fire
images are useful to ensure the correct position of the needle
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& The needle can be used as a lever: the entry of the
needle has to be located about 2 cm from the edge of
the transducer and the lesion is manually lifted away
from the chest wall [6].
& Local anaesthesia can be used to move the lesion to a
more convenient place, especially if it is injected deep
to the lesion (Fig. 8).
The macroscopic evaluation of the specimens is also
important, because it can give additional information about
their quality: colour, consistency and grade of immersion of
the cylinders in formaldehyde can be useful criteria for
knowing their suitability for diagnosis. Intact, white or
brown samples that quickly sink are considered more
representative and are consequently preferred to frag-
mented, floating yellow ones, normally containing only
adipose tissue [17]. This is the first index of correlation; of
course it is not conclusive, but only orientative (Fig. 9). If
the biopsied lesion is a cluster of microcalcifications, a
specimen radiograph is mandatory to confirm the presence
of microcalcifications (Fig. 10).
Four specimens may be enough for a reliable diagnosis,
according to Fishman et al. [17]. However, other authors
find a diagnosis with only two specimens to be reliable
[18].
Vacuum-assisted biopsy devices under ultrasound guid-
ance have been used as an alternative to conventional
ultrasound CNB. When VAB is performed, more specimens
are removed [19].
However, Philpotts et al. [20] compared the two
techniques (181 CNB procedures vs 100 VAB procedures)
and found no significant differences in false-negative
Fig. 7 Diamond-shaped needle tips are better than conventional ones
to traverse the fibrous tissue
Fig. 8 The injection of local
anaesthesia below the lesion
can move it to a more superficial
position
Fig. 9 White specimens that sink are usually more representative than
floating yellow specimens
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results, underestimation and complications. The reason for
such a result is probably the homogeneity of most
ultrasound-detected lesions (a small specimen is represen-
tative of the whole lesion) and the low frequency of
borderline results (such as atypical ductal hyperplasia and
others, which are usually associated with microcalcifica-
tions and are not seen on ultrasound).
However, the number of samples should be greater for
those lesions with complex radiological features. In these
cases, for example parenchymal distortions or asymmetric
densities, more samples and/or thicker needles are recom-
mended. The first cylinders are the most important ones,
because later the suspicious lesion can be masked by
variable degrees of bleeding.
Results
After the initial results by Parker and co-workers, with a
100% correlation with surgical results for 49 excised
masses and no additional cancers in the remaining 132
cases, all the published series have shown excellent results
(Table 1) [7–10, 17, 21–26]. Sensitivity of ultrasound-
guided CNB is about 97.5%, which makes this technique a
very good choice for performing a breast biopsy. In
published series 10% of lesions required repeat biopsy,
17% of which had malignancy [27]. Most of the cancers
that were not initially diagnosed were biopsied again after
new evaluation. Radiological–pathological correlation is
the clue to diagnosing those missed cancers. Therefore, the
correlation between radiological and histological findings is
very important.
Radiological–pathological correlation
Despite performing an optimised biopsy procedure, a false-
negative result can occur. In the case of microcalcifications,
the specimen radiograph is very useful for confirming them
in the removed tissue. However, the specimen radiograph
does not give additional information on non-calcified
lesions. Post-biopsy mammography usually shows no
substantial alteration in the target lesion with conventional
14-gauge needles. Therefore, the radiological–histological
correlation is crucial to avoid false-negative results.
Five situations of radiological–histological correlation
can occur [28]:
– Concordant malignancy: a lesion that is radiologically
suspicious for malignancy (BI-RADS category 4 or 5)
is histologically diagnosed as malignant after core
Fig. 10 Specimen radiograph showing microcalcifications. The
radiograph was taken in a digital mammographic unit (Inspiration,
Siemens, Erlangen, Germany) at 23 KV and 9 mAs. The cylinders
were collected into a plastic cassette
Authors Year Total number of cancers Cancers diagnosed (sensitivity)
Parker et al. [9] 1993 34 34 (100%)
Liberman et al. [8] 1998 58 56 (97%)
Schulz-Wendtland et al. [7] 1998 188 184 (98%)
Smith et al. [21] 2001 128 124 (97%)
Schoonjans and Brem [22] 2001 243 234 (96%)
Bolívar et al. [23] 2005 118 114 (97%)
Crystal et al. [24] 2005 323 311 (96%)
Dillon et al. [25] 2005 769 756 (98%)
Murta de Lucena et al. [17] 2007 101 95 (94%)
Schueller et al. [10] 2008 709 698 (98.5%)
Youk et al. [26] 2010 1,982 1,932 (97.5%)
TOTAL 4,653 4,538 (97.5%)
Table 1 Results for breast
ultrasound-guided CNB series
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biopsy (B4 or B5). Adequate treatment should be
performed.
– Discordant malignancy: a radiologically benign lesion
(BI-RADS 2 or 3) is finally diagnosed as histologically
malignant after core biopsy (B4 or B5). Adequate
treatment should be performed.
– Concordant benignity: the radiological findings are
benign or low–intermediate suspicious (BI-RADS 2, 3,
4a, 4b), and histological features are benign (B1 or B2
categories). An adequate radiological–pathological cor-
relation should be established, and imaging follow-up
should be offered to avoid delayed false-negative
results. Exceptionally, some of these lesions can be
surgically or percutaneously excised because of patient
anxiety, patient decision or physician preference.
– Discordant benignity: a radiologically malignant lesion
(BI-RADS category 4c or 5) is proved to be benign
after core biopsy. In this case, both the imaging and the
pathological findings should be reviewed again. It is
imperative to find a diagnosis; therefore, a new
percutaneous biopsy (including vacuum-assisted breast
biopsy) or a surgical removal can be offered.
– Borderline findings: atypical ductal hyperplasia, lobular
neoplasm, radial scar, papillary lesion and phyllodes
tumour, are classified as B3 pathological results and
usually require the removal of the whole lesion. It has
been demonstrated that the rates of underestimation
decrease as the number and calibre of samples increase
[29]. In cases of atypical ductal hyperplasia or radial
scar with atypia, a surgical biopsy is probably the best
option because it is possible to find histological
features of ductal carcinoma in situ or even invasive
carcinoma in the surrounding tissue.
Complications
The complications of ultrasound CNB are infrequent and
not significant. Both haematomas and infections are very
rare, accounting for less than 1/1,000 biopsies [5], being
similar to the complications of other percutaneous biopsy
devices. The possibility of pneumothorax exists [30], but it
is very rare using the free-hand technique and a horizontal
approach. Patients should be informed about the possible
complications of the technique.
One complication of all percutaneous biopsies is
epithelial displacement. It was first described by Harter et
al. [31] in 1992. In 1999, Diaz et al. [32] concluded that
epithelial displacement was seen in up to 37% of all
biopsies. However, the displaced cells did not seem to be
viable. Later, in 2002, Chen et al. [33] compared the
recurrences after percutaneous biopsies vs surgical biopsies
in patients with breast-conserving therapy, and found no
significant differences in recurrence rates. Thus, whatever
the method of biopsy, the recurrence rate was similar.
Conclusion
All BI-RADS 4 and BI-RADS 5 lesions, and some BI-
RADS 3 ones, should be percutaneously punctured, and in
cases with benign results, surgery can be avoided if there is
a good radiological–pathological correlation and no bor-
derline result is obtained. Ultrasound CNB is a well-known,
safe and accurate technique that is currently considered the
elective method, whereas stereotaxy and MRI should be
reserved for lesions that are not clearly seen on ultrasound.
Complications are infrequent and not serious.
For these reasons, we would encourage all breast
radiologists to gain plenty of experience of this technique.
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